StonvexLoading…
StonvexStonvexStonvexCore line items from TXRH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-30 | Annual 2024 2024-12-31 | Annual 2023 2023-12-26 | Annual 2022 2022-12-27 |
|---|---|---|---|---|
Revenue | $5.88B | $5.37B | $4.63B | $4.01B |
Operating Income | $474.74M | $516.52M | $353.99M | $320.20M |
Net Income | $414.33M | $444.35M | $313.68M | $269.82M |
EPS (Diluted) | $6.10 | $6.47 | $4.54 | $3.97 |
Total Assets | $3.55B | $3.19B | $2.79B | $2.53B |
Total Liabilities | $2.07B | $1.82B | $1.64B | $1.50B |
Cash & Equivalents | $134.71M | $245.22M | $104.25M | $173.86M |
Free Cash Flow OCF − CapEx | $342.07M | $399.29M | $217.95M | $265.60M |
Shares Outstanding | 65.94M | 66.57M | 66.79M | 66.97M |